KXL® System

The corneal cross-linking solution for your keratoconus & Lasik Xtra® patients

The KXL® system has a sleek, mobile design with a large touchscreen and wireless remote control that makes it easier to use. Together with 4 preset (changeable) protocols, a fifth user programmable treatment protocol, and the Glaukos family of high-quality riboflavin formulations, you can choose from proven and predictable protocols for your patients via epithelium-off (epi-off), accelerated, pulsed, or continuous treatments.

Download the KXL® brochure
A patient and doctor with the KXL® system for performing cross-linking and Lasik Xtra®
A patient and doctor with the KXL® system for performing cross-linking and Lasik Xtra®

The KXL® system features:

  • Up to 45 mW/cm2 of power for effective cross-linking
  • Wireless remote control for accurate and convenient X, Y, and Z axis adjustments during treatment
  • Large 25.7 cm touchscreen monitor for premium operator visibility and ease of use
  • 4 preset treatment protocols for safety, efficiency, and accuracy
  • Fifth user programmable treatment protocol for convenience
  • Intuitive software user interface
  • Live camera for ease of alignment and image acquisition
  • On-board patient database for easy reference and planning
  • Exportable patient treatment report for record keeping

Procedures performed with the KXL® system include cross-linking and Lasik Xtra®.


Screenshots of the the KXL ® treatment report available through the KXL ® system.

Download the operator's manual for the KXL® system

Download

Download the operator's manual for the updated KXL® system

Download

We want to hear from you!

Please contact us to learn more about our cross-linking products and procedures.

Glaukos will use the information you provide on this form to be in touch with you.*

Intended Use

The KXL® System is intended for illuminating the cornea during corneal cross-linking procedures stabilizing cornea which have been weakened by disease or by refractive surgery.

Safety Information

The KXL® System is contraindicated where the corneal thickness, with epithelium, is less than < 375 microns, in corneal melting disorders, aphakic patients, pseudophakic patients without UV blocking lens implanted, pregnant and nursing women, and children. Possible risks may include corneal haze, delayed epithelial healing, corneal edema, stromal scarring, keratitis by infection and sterile infiltrates. For full information consult the directions for use.